Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”

Detalles Bibliográficos
Autores principales: Cherin, Patrick, Delain, Jean-Christophe, Crave, Jean-Charles, Cartry, Odile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407618/
https://www.ncbi.nlm.nih.gov/pubmed/25949842
http://dx.doi.org/10.1155/2015/436736
_version_ 1782367941282496512
author Cherin, Patrick
Delain, Jean-Christophe
Crave, Jean-Charles
Cartry, Odile
author_facet Cherin, Patrick
Delain, Jean-Christophe
Crave, Jean-Charles
Cartry, Odile
author_sort Cherin, Patrick
collection PubMed
description
format Online
Article
Text
id pubmed-4407618
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-44076182015-05-06 Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis” Cherin, Patrick Delain, Jean-Christophe Crave, Jean-Charles Cartry, Odile Case Rep Rheumatol Corrigendum Hindawi Publishing Corporation 2015 2015-04-09 /pmc/articles/PMC4407618/ /pubmed/25949842 http://dx.doi.org/10.1155/2015/436736 Text en Copyright © 2015 Patrick Cherin et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Cherin, Patrick
Delain, Jean-Christophe
Crave, Jean-Charles
Cartry, Odile
Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”
title Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”
title_full Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”
title_fullStr Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”
title_full_unstemmed Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”
title_short Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”
title_sort corrigendum to “high-dose subcutaneous immunoglobulins for the treatment of severe treatment-resistant polymyositis”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407618/
https://www.ncbi.nlm.nih.gov/pubmed/25949842
http://dx.doi.org/10.1155/2015/436736
work_keys_str_mv AT cherinpatrick corrigendumtohighdosesubcutaneousimmunoglobulinsforthetreatmentofseveretreatmentresistantpolymyositis
AT delainjeanchristophe corrigendumtohighdosesubcutaneousimmunoglobulinsforthetreatmentofseveretreatmentresistantpolymyositis
AT cravejeancharles corrigendumtohighdosesubcutaneousimmunoglobulinsforthetreatmentofseveretreatmentresistantpolymyositis
AT cartryodile corrigendumtohighdosesubcutaneousimmunoglobulinsforthetreatmentofseveretreatmentresistantpolymyositis

Ejemplares similares